World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia.
| WHO classification of myeloid neoplasms and acute leukemia |
|---|
| Acute myeloid leukemia (AML) and related neoplasms |
| AML with recurrent genetic abnormalities |
| AML with t(8;21)(q22q22.1); |
| AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); |
| APL with |
| AML with t(9;11)(p21.3;q23.3); |
| AML with t(6;9)(p23;q34.1); |
| AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); |
| AML (megakaryoblastic) with t(1;22)(p13.3;q13.1); |
| AML with mutated |
| AML with biallelic mutation of |
| AML with myelodysplasia-related changes |
| Therapy-related myeloid neoplasms |
| AML, not otherwise specified (NOS) |
| AML with minimal differentiation |
| AML without maturation |
| AML with maturation |
| Acute myelomonocytic leukemia |
| Acute monoblastic and monocytic leukemia |
| Pure erythroid leukemia |
| Acute megakaryoblastic leukemia |
| Acute basophilic leukemia |
| Acute panmyelosis with myelofibrosis |
| Myeloid sarcoma |
| Myeloid proliferations associated with Down syndrome |
| Transient abnormal myelopoiesis (TAM) associated with Down syndrome |
| Myeloid leukemia associated with Down syndrome |
Blood Res 2020;55:S1~S4 https://doi.org/10.5045/br.2020.S001
© Blood Research
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd